根据就诊时的功能障碍程度,对成人颈椎畸形矫正手术后临床改善的预期。

IF 1.6 Q3 CLINICAL NEUROLOGY
Spine deformity Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI:10.1007/s43390-024-00896-x
Peter G Passias, Oluwatobi O Onafowokan, Rachel Joujon-Roche, Justin Smith, Peter Tretiakov, Thomas Buell, Bassel G Diebo, Alan H Daniels, Jeffrey L Gum, D Kojo Hamiltion, Alex Soroceanu, Justin Scheer, Robert K Eastlack, Richard G Fessler, Eric O Klineberg, Han Jo Kim, Douglas C Burton, Frank J Schwab, Shay Bess, Virginie Lafage, Christopher I Shaffrey, Christopher Ames
{"title":"根据就诊时的功能障碍程度,对成人颈椎畸形矫正手术后临床改善的预期。","authors":"Peter G Passias, Oluwatobi O Onafowokan, Rachel Joujon-Roche, Justin Smith, Peter Tretiakov, Thomas Buell, Bassel G Diebo, Alan H Daniels, Jeffrey L Gum, D Kojo Hamiltion, Alex Soroceanu, Justin Scheer, Robert K Eastlack, Richard G Fessler, Eric O Klineberg, Han Jo Kim, Douglas C Burton, Frank J Schwab, Shay Bess, Virginie Lafage, Christopher I Shaffrey, Christopher Ames","doi":"10.1007/s43390-024-00896-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess impact of baseline disability on HRQL outcomes.</p><p><strong>Methods: </strong>CD patients with baseline (BL) and 2 year (2Y) data included, and ranked into quartiles by baseline NDI, from lowest/best score (Q1) to highest/worst score (Q4). Means comparison tests analyzed differences between quartiles. ANCOVA and logistic regressions assessed differences in outcomes while accounting for covariates (BL deformity, comorbidities, HRQLs, surgical details and complications).</p><p><strong>Results: </strong>One hundred and sixteen patients met inclusion (Age:60.97 ± 10.45 years, BMI: 28.73 ± 7.59 kg/m<sup>2</sup>, CCI: 0.94 ± 1.31). The cohort mean cSVA was 38.54 ± 19.43 mm and TS-CL: 37.34 ± 19.73. Mean BL NDI by quartile was: Q1: 25.04 ± 8.19, Q2: 41.61 ± 2.77, Q3: 53.31 ± 4.32, and Q4: 69.52 ± 8.35. Q2 demonstrated greatest improvement in NRS Neck at 2Y (-3.93), compared to Q3 (-1.61, p = .032) and Q4 (-1.41, p = .015). Q2 demonstrated greater improvement in NRS Back (-1.71), compared to Q4 (+ 0.84, p = .010). Q2 met MCID in NRS Neck at the highest rates (69.9%), especially compared to Q4 (30.3%), p = .039. Q2 had the greatest improvement in EQ-5D (+ 0.082), compared to Q1 (+ 0.073), Q3 (+ 0.022), and Q4 (+ 0.014), p = .034. Q2 also had the greatest mJOA improvement (+ 1.517), p = .042.</p><p><strong>Conclusions: </strong>Patients in Q2, with mean BL NDI of 42, consistently demonstrated the greatest improvement in HRQLs whereas those in Q4, (NDI 70), saw the least. BL NDI between 39 and 44 may represent a disability \"Sweet Spot,\" within which operative intervention maximizes patient-reported outcomes. Furthermore, delaying intervention until patients are severely disabled, beyond an NDI of 61, may limit the benefits of surgery.</p>","PeriodicalId":21796,"journal":{"name":"Spine deformity","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expectations of clinical improvement following corrective surgery for adult cervical deformity based on functional disability at presentation.\",\"authors\":\"Peter G Passias, Oluwatobi O Onafowokan, Rachel Joujon-Roche, Justin Smith, Peter Tretiakov, Thomas Buell, Bassel G Diebo, Alan H Daniels, Jeffrey L Gum, D Kojo Hamiltion, Alex Soroceanu, Justin Scheer, Robert K Eastlack, Richard G Fessler, Eric O Klineberg, Han Jo Kim, Douglas C Burton, Frank J Schwab, Shay Bess, Virginie Lafage, Christopher I Shaffrey, Christopher Ames\",\"doi\":\"10.1007/s43390-024-00896-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To assess impact of baseline disability on HRQL outcomes.</p><p><strong>Methods: </strong>CD patients with baseline (BL) and 2 year (2Y) data included, and ranked into quartiles by baseline NDI, from lowest/best score (Q1) to highest/worst score (Q4). Means comparison tests analyzed differences between quartiles. ANCOVA and logistic regressions assessed differences in outcomes while accounting for covariates (BL deformity, comorbidities, HRQLs, surgical details and complications).</p><p><strong>Results: </strong>One hundred and sixteen patients met inclusion (Age:60.97 ± 10.45 years, BMI: 28.73 ± 7.59 kg/m<sup>2</sup>, CCI: 0.94 ± 1.31). The cohort mean cSVA was 38.54 ± 19.43 mm and TS-CL: 37.34 ± 19.73. Mean BL NDI by quartile was: Q1: 25.04 ± 8.19, Q2: 41.61 ± 2.77, Q3: 53.31 ± 4.32, and Q4: 69.52 ± 8.35. Q2 demonstrated greatest improvement in NRS Neck at 2Y (-3.93), compared to Q3 (-1.61, p = .032) and Q4 (-1.41, p = .015). Q2 demonstrated greater improvement in NRS Back (-1.71), compared to Q4 (+ 0.84, p = .010). Q2 met MCID in NRS Neck at the highest rates (69.9%), especially compared to Q4 (30.3%), p = .039. Q2 had the greatest improvement in EQ-5D (+ 0.082), compared to Q1 (+ 0.073), Q3 (+ 0.022), and Q4 (+ 0.014), p = .034. Q2 also had the greatest mJOA improvement (+ 1.517), p = .042.</p><p><strong>Conclusions: </strong>Patients in Q2, with mean BL NDI of 42, consistently demonstrated the greatest improvement in HRQLs whereas those in Q4, (NDI 70), saw the least. BL NDI between 39 and 44 may represent a disability \\\"Sweet Spot,\\\" within which operative intervention maximizes patient-reported outcomes. Furthermore, delaying intervention until patients are severely disabled, beyond an NDI of 61, may limit the benefits of surgery.</p>\",\"PeriodicalId\":21796,\"journal\":{\"name\":\"Spine deformity\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spine deformity\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s43390-024-00896-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spine deformity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s43390-024-00896-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估基线残疾对 HRQL 结果的影响:纳入具有基线(BL)和两年(2Y)数据的 CD 患者,并按基线 NDI 从最低/最佳得分(Q1)到最高/最差得分(Q4)分为四等分。均值比较检验分析了四分位数之间的差异。方差分析和逻辑回归在考虑协变量(BL畸形、合并症、HRQLs、手术细节和并发症)的情况下评估结果的差异:116名患者符合纳入条件(年龄:60.97 ± 10.45岁,体重指数:28.73 ± 7.59 kg/m2,CCI:0.94 ± 1.31)。队列平均 cSVA 为 38.54 ± 19.43 mm,TS-CL 为 37.34 ± 19.73。各四分位数的 BL NDI 平均值为Q1:25.04 ± 8.19;Q2:41.61 ± 2.77;Q3:53.31 ± 4.32;Q4:69.52 ± 8.35。2 年后,第二季度颈部 NRS 改善最大(-3.93),而第三季度(-1.61,p = 0.032)和第四季度(-1.41,p = 0.015)。与第四季度(+ 0.84,p = .010)相比,第二季度的 NRS 背部改善幅度更大(-1.71)。与第四季度(30.3%)相比,第二季度的 NRS Neck 符合 MCID 的比例最高(69.9%),p = .039。与 Q1(+ 0.073)、Q3(+ 0.022)和 Q4(+ 0.014)相比,Q2 的 EQ-5D 改善幅度最大(+ 0.082),p = .034。第二季度的 mJOA 改善幅度也最大(+ 1.517),p = .042:第 2 季度患者的平均 BL NDI 为 42,其 HRQL 改善幅度最大,而第 4 季度患者(NDI 为 70)的 HRQL 改善幅度最小。BL NDI 在 39 到 44 之间可能代表了残疾 "甜蜜点",在此范围内进行手术干预可使患者报告的结果最大化。此外,延迟干预直到患者严重残疾,即 NDI 超过 61,可能会限制手术的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Expectations of clinical improvement following corrective surgery for adult cervical deformity based on functional disability at presentation.

Purpose: To assess impact of baseline disability on HRQL outcomes.

Methods: CD patients with baseline (BL) and 2 year (2Y) data included, and ranked into quartiles by baseline NDI, from lowest/best score (Q1) to highest/worst score (Q4). Means comparison tests analyzed differences between quartiles. ANCOVA and logistic regressions assessed differences in outcomes while accounting for covariates (BL deformity, comorbidities, HRQLs, surgical details and complications).

Results: One hundred and sixteen patients met inclusion (Age:60.97 ± 10.45 years, BMI: 28.73 ± 7.59 kg/m2, CCI: 0.94 ± 1.31). The cohort mean cSVA was 38.54 ± 19.43 mm and TS-CL: 37.34 ± 19.73. Mean BL NDI by quartile was: Q1: 25.04 ± 8.19, Q2: 41.61 ± 2.77, Q3: 53.31 ± 4.32, and Q4: 69.52 ± 8.35. Q2 demonstrated greatest improvement in NRS Neck at 2Y (-3.93), compared to Q3 (-1.61, p = .032) and Q4 (-1.41, p = .015). Q2 demonstrated greater improvement in NRS Back (-1.71), compared to Q4 (+ 0.84, p = .010). Q2 met MCID in NRS Neck at the highest rates (69.9%), especially compared to Q4 (30.3%), p = .039. Q2 had the greatest improvement in EQ-5D (+ 0.082), compared to Q1 (+ 0.073), Q3 (+ 0.022), and Q4 (+ 0.014), p = .034. Q2 also had the greatest mJOA improvement (+ 1.517), p = .042.

Conclusions: Patients in Q2, with mean BL NDI of 42, consistently demonstrated the greatest improvement in HRQLs whereas those in Q4, (NDI 70), saw the least. BL NDI between 39 and 44 may represent a disability "Sweet Spot," within which operative intervention maximizes patient-reported outcomes. Furthermore, delaying intervention until patients are severely disabled, beyond an NDI of 61, may limit the benefits of surgery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.20
自引率
18.80%
发文量
167
期刊介绍: Spine Deformity the official journal of the?Scoliosis Research Society is a peer-refereed publication to disseminate knowledge on basic science and clinical research into the?etiology?biomechanics?treatment?methods and outcomes of all types of?spinal deformities. The international members of the Editorial Board provide a worldwide perspective for the journal's area of interest.The?journal?will enhance the mission of the Society which is to foster the optimal care of all patients with?spine?deformities worldwide. Articles published in?Spine Deformity?are Medline indexed in PubMed.? The journal publishes original articles in the form of clinical and basic research. Spine Deformity will only publish studies that have institutional review board (IRB) or similar ethics committee approval for human and animal studies and have strictly observed these guidelines. The minimum follow-up period for follow-up clinical studies is 24 months.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信